| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Engleman Edgar serves as a Director, 10% Owner at SLNO and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 8 buys and 14 sells. Those positions are worth an estimated $7.2M at current prices.
Historically, Engleman Edgar's trades have earned a middling insider score of 60/100 across 6 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +34.4%.
The biggest single holding is SLNO (~$7.0M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 2,573,693 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | BOLT Bolt Biotherapeutics, Inc. | Director | Sell | 148,884 | $0.87 | $128,993.42 | -37.2% | +39.5% | -24.9% | |
| Nov 21, 2023 | BOLT Bolt Biotherapeutics, Inc. | Director | Sell | 1,943 | $0.90 | $1,751.42 | -0.7% | +32.9% | -34.1% | |
| Nov 20, 2023 | BOLT Bolt Biotherapeutics, Inc. | Director | Sell | 49,173 | $0.93 | $45,675.45 | -15.4% | +25.7% | -38.7% | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | Director, 10% Owner | Sell | 164 | $20.00 | $3,280.00 | - | - | - | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | Director, 10% Owner | Buy | 200,000 | $20.00 | $4,000,000.00 | +263.9% | - | - | |
| Dec 15, 2017 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 1,085,480 | $1.84 | $1,999,996.90 | +36.8% | - | - | |
| Mar 7, 2017 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 1,488,213 | $0.91 | $1,354,042.56 | +11.3% | - | - |